Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research note released on Sunday. The brokerage issued a hold rating on the software maker’s stock.

Several other research firms have also commented on MDRX. Deutsche Bank Aktiengesellschaft reiterated a hold rating and issued a $10.00 price objective (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Barclays started coverage on Veradigm in a research report on Wednesday, January 3rd. They issued an equal weight rating and a $11.00 price objective on the stock. Finally, Royal Bank of Canada lowered their target price on Veradigm from $22.00 to $11.00 and set an outperform rating on the stock in a research note on Friday, January 19th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of Hold and an average price target of $11.25.

Veradigm Stock Performance

Shares of MDRX stock opened at $8.15 on Friday. The firm has a 50-day moving average of $8.01 and a 200-day moving average of $10.41. Veradigm has a one year low of $5.01 and a one year high of $14.09.

Hedge Funds Weigh In On Veradigm

Several institutional investors have recently bought and sold shares of MDRX. Quarry LP bought a new stake in shares of Veradigm in the first quarter valued at $37,000. TFO Wealth Partners LLC raised its stake in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after acquiring an additional 5,264 shares during the period. Gladius Capital Management LP lifted its holdings in Veradigm by 135.0% during the fourth quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock valued at $66,000 after purchasing an additional 3,587 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in Veradigm by 95.0% during the second quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker’s stock worth $67,000 after purchasing an additional 2,587 shares during the period. Finally, Envestnet Asset Management Inc. boosted its position in Veradigm by 27.4% during the first quarter. Envestnet Asset Management Inc. now owns 32,691 shares of the software maker’s stock worth $69,000 after purchasing an additional 7,027 shares during the period.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.